Psoriasis Active Not Recruiting Phase 3 Trials for Erythrityl Tetranitrate (DB01613)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02346240Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)Treatment